dimethyl 5-aminopyridine-3,4-dicarboxylate | 98953-45-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: dimethyl 5-aminopyridine-3,4-dicarboxylate
• 英文别名: 3-Amino-pyridin-4,5-dicarbonsaeure-dimethylester；5-amino-pyridine-3,4-dicarboxylic acid dimethyl ester
• CAS: 98953-45-8
• 化学式: C₉H₁₀N₂O₄
• 分子量: 210.189
• InChiKey: HTPDHVNVUWRFLJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  91.5
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  dimethyl 5-aminopyridine-3,4-dicarboxylate 在 potassium hydroxide 作用下， 以 四氢呋喃 为溶剂， 反应 3.0h， 生成 N-(1,3-dioxo-1,3-dihydrofuro[3,4-c]pyridin-7-yl)acetamide
  参考文献：
  名称：

  NOVEL ISOINDOLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

  摘要：

  公开号：

  EP3590924B1
• 作为产物：
  描述：

  dimethyl 5-((2,4-dimethoxybenzyl)amino)pyridine-3,4-dicarboxylate 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以1.15g的产率得到dimethyl 5-aminopyridine-3,4-dicarboxylate
  参考文献：
  名称：

  NOVEL ISOINDOLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

  摘要：

  公开号：

  EP3590924B1

文献信息

• Isoindoline derivative, pharmaceutical composition and use thereof
  申请人：Kangpu Biopharmaceuticals, Ltd.

  公开号：US11337964B2

  公开（公告）日：2022-05-24

  Disclosed are a novel isoindoline derivative, a pharmaceutical composition and use thereof. The compound of formula I, or the pharmaceutically acceptable salt, solvate, polymorph, co-crystal, stereoisomer, isotopic compound, metabolite or prodrug thereof disclosed in the invention can regulate the generation and/or activity of PDE4 and/or TNF-α so as to effectively treat cancer and inflammatory diseases.

  本发明公开了一种新型异吲哚啉衍生物、一种药物组合物及其用途。本发明公开的式 I 化合物或其药学上可接受的盐、溶液剂、多晶型、共晶体、立体异构体、同位素化合物、代谢物或原药可以调节 PDE4 和/或 TNF-α 的生成和/或活性，从而有效治疗癌症和炎症性疾病。
• NOVEL ISOINDOLINE DERIVATIVE, A PHARMACEUTICAL COMPOSITION AND USE THEREOF
  申请人：Kangpu Biopharmaceuticals, Ltd.

  公开号：US20200061033A1

  公开（公告）日：2020-02-27

  Disclosed are a novel isoindoline derivative, a pharmaceutical composition and use thereof. The compound of formula I, or the pharmaceutically acceptable salt, solvate, polymorph, co-crystal, stereoisomer, isotopic compound, metabolite or prodrug thereof disclosed in the invention can regulate the generation and/or activity of PDE4 and/or TNF-α so as to effectively treat cancer and inflammatory diseases.
• ISOINDOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
  申请人：Kangpu Biopharmaceuticals, Ltd.

  公开号：US20220152002A1

  公开（公告）日：2022-05-19

  Disclosed are a novel isoindoline derivative, a pharmaceutical composition and use thereof. The compound of formula I, or the pharmaceutically acceptable salt, solvate, polymorph, co-crystal, stereoisomer, isotopic compound, metabolite or prodrug thereof disclosed in the invention can regulate the generation and/or activity of PDE4 and/or TNF-α, so as to effectively treat cancer and inflammatory diseases.